316 related articles for article (PubMed ID: 32579693)
1. Management and Visual Outcomes of Acute Bacterial Endophthalmitis Following Intravitreal Injection of Contaminated Bevacizumab in a Single Day.
Xu K; Mousa R; Loewenstein A; Barak A; Chin EK; Almeida DRP
Ophthalmic Surg Lasers Imaging Retina; 2020 Jun; 51(6):346-352. PubMed ID: 32579693
[TBL] [Abstract][Full Text] [Related]
2. Endophthalmitis after Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Management and Visual Outcomes.
Xu K; Chin EK; Bennett SR; Williams DF; Ryan EH; Dev S; Mittra RA; Quiram PA; Davies JB; Parke DW; Johnson JB; Cantrill HL; Almeida DRP
Ophthalmology; 2018 Aug; 125(8):1279-1286. PubMed ID: 29477689
[TBL] [Abstract][Full Text] [Related]
3. Changes in Management Based on Vitreous Culture in Endophthalmitis After Intravitreal Anti-vascular Endothelial Growth Factor Injection.
Patel SN; Storey PP; Pancholy M; Obeid A; Wibbelsman TD; Levin H; Hsu J; Garg SJ; Dunn JP; Vander JF
Am J Ophthalmol; 2019 Nov; 207():224-231. PubMed ID: 31201794
[TBL] [Abstract][Full Text] [Related]
4. A Large Outbreak of Fulminant Bacterial Endophthalmitis after Intravitreal Injection of Counterfeit Bevacizumab.
Entezari M; Karimi S; Ahmadieh H; Mahmoudi AH; Parhizgar H; Yaseri M
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1851-6. PubMed ID: 27377655
[TBL] [Abstract][Full Text] [Related]
5. Acute bilateral endophthalmitis following bilateral intravitreal bevacizumab (avastin) injection.
Tabatabaii A; Ahmadraji A; Khodabande A; Mansouri M
Middle East Afr J Ophthalmol; 2013; 20(1):87-8. PubMed ID: 23580860
[TBL] [Abstract][Full Text] [Related]
6. LONG-TERM VISUAL OUTCOMES AND CLINICAL FEATURES AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTION-RELATED ENDOPHTHALMITIS.
Rayess N; Obeid A; Storey PP; Juliano J; Rahimy E; Moshfeghi AA; Garg S; Hsu J
Retina; 2019 Nov; 39(11):2070-2076. PubMed ID: 30157114
[TBL] [Abstract][Full Text] [Related]
7. Pars plana vitrectomy in the management of patients diagnosed with endophthalmitis following intravitreal anti-vascular endothelial growth factor injection.
Chaudhary KM; Romero JM; Ezon I; Fastenberg DM; Deramo VA
Retina; 2013; 33(7):1407-16. PubMed ID: 23492945
[TBL] [Abstract][Full Text] [Related]
8.
Beri S; Shandil A; Garg R
Indian J Ophthalmol; 2017 Nov; 65(11):1166-1171. PubMed ID: 29133644
[TBL] [Abstract][Full Text] [Related]
9. An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab.
Goldberg RA; Flynn HW; Isom RF; Miller D; Gonzalez S
Am J Ophthalmol; 2012 Feb; 153(2):204-208.e1. PubMed ID: 22264943
[TBL] [Abstract][Full Text] [Related]
10. Streptococcus endophthalmitis outbreak after intravitreal injection of bevacizumab: one-year outcomes and investigative results.
Goldberg RA; Flynn HW; Miller D; Gonzalez S; Isom RF
Ophthalmology; 2013 Jul; 120(7):1448-53. PubMed ID: 23453511
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Prefilled Syringes on Endophthalmitis Following Intravitreal Injection of Ranibizumab.
Storey PP; Tauqeer Z; Yonekawa Y; Todorich B; Wolfe JD; Shah SP; Shah AR; Koto T; Abbey AM; Morizane Y; Sharma P; Wood EH; Morizane-Hosokawa M; Pendri P; Pancholy M; Harkey S; Jeng-Miller KW; Obeid A; Borkar DS; Chen E; Williams P; Okada AA; Inoue M; Shiraga F; Hirakata A; Shah CP; Prenner J; Garg S;
Am J Ophthalmol; 2019 Mar; 199():200-208. PubMed ID: 30552891
[TBL] [Abstract][Full Text] [Related]
12. Clinical features, management, and outcomes of patients with sterile endophthalmitis associated with intravitreal bevacizumab injection: retrospective case series.
Kivrak U; Arsan AK; Akçay G; Bulut MN; Kanar HS; Hacısalihoğlu AO; Şimşek Ş
Int Ophthalmol; 2024 May; 44(1):216. PubMed ID: 38705908
[TBL] [Abstract][Full Text] [Related]
13. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
Shah CP; Garg SJ; Vander JF; Brown GC; Kaiser RS; Haller JA;
Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087
[TBL] [Abstract][Full Text] [Related]
14. Cluster endophthalmitis following multiple intravitreal bevacizumab injections from a single use vial.
Khan P; Khan L; Mondal P
Indian J Ophthalmol; 2016 Sep; 64(9):694-696. PubMed ID: 27853027
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of endophthalmitis after an injection of intravitreal antivascular endothelial growth factor.
Mezad-Koursh D; Goldstein M; Heilwail G; Zayit-Soudry S; Loewenstein A; Barak A
Retina; 2010; 30(7):1051-7. PubMed ID: 20616683
[TBL] [Abstract][Full Text] [Related]
16. Cluster endophthalmitis due to
Agarwal AK; Aggarwal K; Samanta R; Angrup A; Biswal M; Ray P; Dogra M; Katoch D; Bansal R; Singh R; Dogra MR; Gupta V
Br J Ophthalmol; 2019 Sep; 103(9):1278-1283. PubMed ID: 30420442
[TBL] [Abstract][Full Text] [Related]
17. MICROBIAL SPECTRUM AND OUTCOMES OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION VERSUS PARS PLANA VITRECTOMY.
Garg SJ; Dollin M; Storey P; Pitcher JD; Fang-Yen NH; Vander J; Hsu J;
Retina; 2016 Feb; 36(2):351-9. PubMed ID: 26200514
[TBL] [Abstract][Full Text] [Related]
18. A Nine-Year Analysis of Practice Patterns, Microbiologic Yield, and Clinical Outcomes in Cases of Presumed Infectious Endophthalmitis.
Feng HL; Robbins CB; Fekrat S
Ophthalmol Retina; 2020 Jun; 4(6):555-559. PubMed ID: 32387054
[TBL] [Abstract][Full Text] [Related]
19. Incidence of Endophthalmitis after Intravitreal Anti-vascular Endothelial Growth Factor: Experience in Saudi Arabia.
Al-Rashaed S; Alsulaiman SM; Alrushood AA; Almasaud J; Arevalo JF
Middle East Afr J Ophthalmol; 2016; 23(1):60-3. PubMed ID: 26957840
[TBL] [Abstract][Full Text] [Related]
20. Incidence and visual outcomes of acute endophthalmitis post intravitreal injection of anti-vascular endothelial growth factors in a single referral center.
Gonzalez-Gonzalez LA; Knickelbein JE; Doft BH; Balasubramani GK; Wisniewski S
Int Ophthalmol; 2023 Mar; 43(3):867-876. PubMed ID: 36103102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
